Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Papa Sylla

Citigroup · covers Technology

Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q2 (7 quarters).

Questions
20on tracked calls
Challenge rate
5%1 of 20 questions
Companies
3questioned at least once
Reporting periods
7with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 20 of 20 questions from 3 companies

COHRCoherent, Inc.11 questions · 6 reporting periods · 0 of 11 challenging
COHR company page →

Calendar 2026 Q1

I'm curious if you can touch a little bit on the mix you are seeing between EML, SiPho and perhaps even VCSEL

Product LaunchMarginInnovation & R&DTranscript · FY2026 Q3 →
Show response

Anderson clarified no significant margin difference between EML and SiPho transceivers, with mix determined by customer application. Both require indium phosphide capacity. 200-gig VCSEL development progressing well.

my first question is around pricing in general from like a transceiver perspective

PricingMarginSupply ChainTranscript · FY2026 Q3 →
Show response

Anderson confirmed healthy pricing dynamics driven by supply-demand imbalance, with 1.6T ASPs higher than 800 gig. Internal component sourcing provides buffer against external price increases.

Calendar 2025 Q4

the prior seven, what kind of workload would those seven engagement or projects relate to? Related to? Or and also for the additional three as well

Product LaunchCloud & AITranscript · FY2026 Q2 →
Show response

Jim described broadening from spine/redundancy to DCI and scale-up network applications. TAM reassessment would be well above prior $2B estimate. Both customers and applications continue to expand.

Any color on where we are at this point? And perhaps ties to that as well, do you have any target in mind on longer term, what kind of mix

Supply ChainCapex InvestmentTranscript · FY2026 Q2 →
Show response

Jim confirmed majority already internal, with internal share expected to grow over time as 6-inch ramps. Will continue external supply for customer and supply chain resilience reasons.

Calendar 2025 Q3

how you are thinking about allocation of your indium phosphide capacity between EML, CW and photodiode

Supply ChainCapex InvestmentTranscript · FY2026 Q1 →
Show response

Jim explained capacity is fungible between EML and CW with allocation decisions made 4-6 months ahead based purely on customer demand mix. No significant profitability difference between EML and CW.

in terms of kind of percentage or even qualitatively, where are you seeing perhaps the larger demand between those 3?

Cloud & AIInnovation & R&DTranscript · FY2026 Q1 →
Show response

Jim confirmed first wave of 1.6T is silicon photonics and EML. VCSEL-based 1.6T using 200G technology expected to begin production mid-calendar 2026 with revenue in second half.

Calendar 2025 Q2

Is the growth kind of primarily coming from multi- data center training or is it more inference?

Show response

Jim confirmed DCI growing even faster than overall comms, driven by multi-datacenter workloads. Dual path to market: own modules plus component sales to other vendors.

any sense of the sub-400 gig kind of demand this quarter and then moving forward?

DemandRevenue GrowthTranscript · FY2025 Q4 →
Show response

Jim confirmed strong near-term demand for 400G and below as many customers still in transition, with market shifting to 800G and 1.6T beginning to layer on top.

Calendar 2025 Q1

what would you maybe attribute primarily your margin outperformance between those three?

MarginCost PressureTranscript · FY2025 Q3 →
Show response

Sherri noted cost reductions slightly larger contributor than pricing in Q3, emphasized yield improvement is ongoing with continued opportunity across all manufacturing processes.

Has the sentiment improved incrementally since then, despite maybe more macro uncertainty?

DemandRevenue GrowthTranscript · FY2025 Q3 →
Show response

Sherri confirmed still cautiously positive on traditional telecom with incremental improvement; DCI smaller but majority growth driver, telecom grew over 20% YoY.

Calendar 2024 Q4

Just wanted to have kind of additional update on where you are in the process. And is the expectation that 200-gig per lane VCSEL could be available

Innovation & R&DProduct LaunchTranscript · FY2025 Q2 →
Show response

Jim confirmed progress on 200G VCSELs, 200G differential EMLs, and CW lasers but declined to specify technology-to-generation mapping for competitive reasons.

LITELumentum Holdings Inc.7 questions · 4 reporting periods · 1 of 7 challenging
LITE company page →

Calendar 2026 Q2

if you can refresh us on the $400 million plus OCS guide for the second half of 2026. Are you running well ahead of it

Revenue GrowthDemandTranscript · FY2026 Q4 →
Show response

Michael said OCS is tracking to $400M (not ahead) after early supply-chain issues, and expects Lumentum to become the #1 OCS supplier in early 2027.

Calendar 2026 Q1

the opportunity around kind of being more vertically integrated as well, kind of providing more ELS type of product

Innovation & R&DProduct LaunchTranscript · FY2026 Q3 →
Show response

CEO described ELS as a very significant opportunity and the primary currency for engaging non-primary CPO customers. Suggested wins are imminent but not yet ready to announce.

I'm just curious on the risk of oversupply, if any, I guess, where would you put that risk?

ChallengingCompetitive DynamicsSupply ChainTranscript · FY2026 Q3 →
Show response

CEO assessed oversupply risk as low, citing active LTA extension discussions with customers and pricing flexibility as evidence. Noted customers would show more reticence if oversupply were expected.

Calendar 2025 Q4

Has that gap extended? And tied to that, it will be helpful to understand how has your longer-term contract or commitment with customers changed

Supply ChainDemandPricingTranscript · FY2026 Q2 →
Show response

Michael confirmed ~25-30% demand-supply imbalance persists. All EML capacity spoken for in LTAs through balance of calendar 2027. Wajid added LTAs have eliminated quarterly price-down negotiations, customers requesting more than LTA volumes enables incremental pricing discussions.

any change on how you are thinking about content or CPO versus the transceiver business

Cloud & AIInnovation & R&DRevenue GrowthTranscript · FY2026 Q2 →
Show response

Michael confirmed CPO content per server roughly on par with transceivers given higher market share. New ELS module opportunity provides ~2-2.5x content gain versus standalone laser chips with decent margins. Wupen added optical scale-up is a brand-new TAM that further improves overall market position.

Calendar 2025 Q3

kind of what's your approach in terms of pricing at this point? Do you have now more levered to even increase further pricing on EML

MarginPricingRevenue GrowthTranscript · FY2026 Q1 →
Show response

Michael confirmed targeted price increases in current guide with broader increases planned in 2026 LTAs. Wajid outlined margin expansion drivers: manufacturing utilization, 200G EML mix shift, plus 1.6T/OCS/CPO contributions in calendar 2026.

how would you characterize the supply-demand this quarter versus last quarter

Supply ChainDemandPricingTranscript · FY2026 Q1 →
Show response

Michael confirmed supply up 10%+ in guide but demand-supply shortfall widened from ~20% to 25-30%. Wupen added newly announced AI projects are extending the horizon of the mismatch, enabling long-term agreements with leading customers.

ALABAstera Labs, Inc. Common Stock2 questions · 2 reporting periods · 0 of 2 challenging
ALAB company page →

Calendar 2026 Q2

I'm wondering if that $1,000+ for Scorpio X is it a pre-UALink metric.

Revenue GrowthPricingTranscript · FY2026 Q2 →
Show response

Sanjay said total content is now multiple thousands of dollars per XPU with Scorpio X alone over $1,000, expecting further scaling from optical and higher signal-conditioning attach.

Calendar 2025 Q2

can you touch a little bit more on the kind of extent of that collaboration.

M&ACompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Management framed the Alchip collaboration as part of enabling an open, interoperable AI rack alongside GPU and ASIC partners.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
COHR Coherent, Inc.110%none of 11 questions
LITE Lumentum Holdings Inc.714%1 of 7 questions
ALAB Astera Labs, Inc. Common Stock2—Rate withheld: fewer than 3 questions
  • COHR
    Coherent, Inc. · 11 questions
    0%none of 11 questions
  • LITE
    Lumentum Holdings Inc. · 7 questions
    14%1 of 7 questions
  • ALAB
    Astera Labs, Inc. Common Stock · 2 questions
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q410%none of 1 question1
2025 Q120%none of 2 questions1
2025 Q230%none of 3 questions2
2025 Q340%none of 4 questions2
2025 Q440%none of 4 questions2
2026 Q1425%1 of 4 questions2
2026 Q220%none of 2 questions2
  1. 2024 Q41 question · challenge rate 0% (none of 1 question) · 1 company
  2. 2025 Q12 questions · challenge rate 0% (none of 2 questions) · 1 company
  3. 2025 Q23 questions · challenge rate 0% (none of 3 questions) · 2 companies
  4. 2025 Q34 questions · challenge rate 0% (none of 4 questions) · 2 companies
  5. 2025 Q44 questions · challenge rate 0% (none of 4 questions) · 2 companies
  6. 2026 Q14 questions · challenge rate 25% (1 of 4 questions) · 2 companies
  7. 2026 Q22 questions · challenge rate 0% (none of 2 questions) · 2 companies

Topics

Topics tagged on this analyst’s questions.

  • Revenue Growth6
  • Demand6
  • Supply Chain6
  • Innovation & R&D5
  • Pricing5
  • Product Launch4
  • Margin4
  • Cloud & AI4
  • Competitive Dynamics2
  • Capex Investment2
Show all 12 topics
  • Cost Pressure1
  • M&A1